What is the pharmacologic action of ipratropium in respiratory therapy?

Unlock all questions

This demo includes only 20 questions. Upgrade to access hundreds of questions, flashcards, exam simulations, and disable ads.

Full question bankExam simulationsFlashcards
From $24.99Unlock all

Prepare for the NCLEX exam effectively with our NCLEX Uworld Practice Test. Use flashcards and multiple choice questions with detailed hints and explanations to ensure you're ready for success!

Multiple Choice

What is the pharmacologic action of ipratropium in respiratory therapy?

Explanation:
Ipclatr opium is an inhaled anticholinergic that blocks muscarinic receptors in the airway smooth muscle. By inhibiting acetylcholine-mediated parasympathetic stimulation, it prevents bronchoconstriction and promotes bronchodilation. This explains its short-acting effect—onset in about 15–30 minutes with a duration of roughly 4–6 hours—classifying it as a short-acting inhaled anticholinergic. It does not work as an anti-inflammatory corticosteroid, nor does it act as a mucolytic to thin mucus, and it is not a beta-adrenergic agonist that directly stimulates beta receptors.

Ipclatr opium is an inhaled anticholinergic that blocks muscarinic receptors in the airway smooth muscle. By inhibiting acetylcholine-mediated parasympathetic stimulation, it prevents bronchoconstriction and promotes bronchodilation. This explains its short-acting effect—onset in about 15–30 minutes with a duration of roughly 4–6 hours—classifying it as a short-acting inhaled anticholinergic. It does not work as an anti-inflammatory corticosteroid, nor does it act as a mucolytic to thin mucus, and it is not a beta-adrenergic agonist that directly stimulates beta receptors.

More Multiple Choice Questions
Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy